For the 74th time, the Congress of the German Society of Urology (DGU) took place in Hamburg last week. In addition to numerous urologists, large pharmaceutical companies and other companies from the field of medical technology, the Moers-based medical technology start-up Medipee also exhibited at the congress for the first time.
At the Moerser booth, everything revolved around the topic of urinalysis. Medipee has developed an innovative system for automatic and contactless urinalysis, which consists of a device and an app. This system enables a fully digitized urinalysis. The device can be attached to any commercial toilet. During daily visits to the toilet, important parameters are measured and then transmitted to the smartphone within seconds.
The first use case of Medipee is the Uroli app: an application that supports patients in the metaphylaxis of urolithiasis and thus reduces recurrent stone results. The device analyzes the pH value and the specific density – two essential parameters in the metaphylaxis of urolithiasis. In addition to urinalysis, Uroli offers a drinking and micturition diary, an intelligent drinking memory, as well as a knowledge area to help patients better understand their disease.
Uroli is planned as a digital health application (DiGA). That is, Uroli is prescribed by the doctor like a drug and reimbursed by the health insurance company. For approval, Medipee is currently conducting a pilot study with several university hospitals. The device is tested here together with patients who have recently had urinary stone surgery. The system supports patients in their follow-up care in everyday life. After the subsequent scientific evaluation, this treatment option will then be registered with the Federal Institute for Drugs and Medical Devices (BfArM) and then listed as a DiGA.
Picture line: The medipee GmbH team in Hamburg
